3185 results for «28»
3185 results
New diagnostic and therapeutical tools in the coronary field
21 May 2025 – From EuroPCR 2025
Explore the latest advancements in diagnostic and therapeutic tools in coronary interventions. This session covers a range of innovative topics including the prognostic impact of QFR-based complete versus incomplete revascularisation, hybrid perfusion quantification with cardiac CT and echocardiography, clinical validation of AI-assisted coronary angiography, national audit...
Challenging vascular access and closure management
21 May 2025 – From EuroPCR 2025
Address challenging vascular access and closure management in complex TAVI cases. This session covers the selection of femoral access, use of PTA and intravascular lithotripsy, and strategies to manage closure failure with illustrative real-world cases.
Optimising CTO outcomes by lesion selection
21 May 2025 – From EuroPCR 2025
Optimize chronic total occlusion (CTO) PCI outcomes through lesion selection strategies. This session reviews coronary calcium patterns via CT, target vessel considerations, distal vessel remodeling, imaging-guided versus conventional approaches, and complex lesion cases.
Novel tools and strategies in chronic heart failure
21 May 2025 – From EuroPCR 2025
Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...
Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.
Multi-modality assessment of coronary disease
21 May 2025 – From EuroPCR 2025
This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...
Optimising self-expandable TAVI clinical outcomes without compromise
22 May 2025 – From EuroPCR 2025
Optimising patient outcomes in self-expandable TAVI starts with a clear plan for today, and tomorrow. This EuroPCR 2025 session explores how to make each step count, from access to implantation and closure, using a real-life case of a 77-year-old woman with severe symptomatic aortic stenosis and...
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients
21 May 2025 – From EuroPCR 2025
Explore cutting-edge strategies in complex PCI through four detailed clinical cases: a challenging left main bifurcation, a complex procedure using Guideliner Extension Catheters (GEC), an acute coronary syndrome intervention, and treatment of a patient with high bleeding and ischemic risks. This session demonstrates how thorough patient...
Prevention of coronary obstruction during TAV-in-TAV
20 May 2025 – From EuroPCR 2025
Examine advanced techniques to prevent coronary obstruction during transcatheter aortic valve-in-valve (TAV-in-TAV) procedures. This session presents complex case strategies including the debated chimney technique and the UNICORN procedure designed for high coronary obstruction risk during redo TAVI interventions.
Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
21 May 2025 – From EuroPCR 2025
Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...
RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer
20 May 2025 – From EuroPCR 2025
Discover how the next-generation RevoEdge high-pressure cutting balloon is transforming PCI with innovative design and proven clinical outcomes. This session presents a multicenter randomised trial and real-world case discussions, showcasing RevoEdge’s effectiveness in tackling resistant, complex lesions—including long, tortuous, and fibrotic cases. Learn practical tips, tricks,...
DCB in challenging scenarios - Part 2
20 May 2025 – From EuroPCR 2025
Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...
Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer
22 May 2025 – From EuroPCR 2025
Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...
Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind”...
Simplify PCI! Know where and how to win with drug-coated balloon
22 May 2025 – From EuroPCR 2025
This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...
Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...
Successful finale - Latest best practices and technologies for large hole arterial and venous closure
22 May 2025 – From EuroPCR 2025
This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.
Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.
The venous case presentation...
Optimal management of high bleeding risk patient with multivessel disease
21 May 2025 – From EuroPCR 2025
This session offers a comprehensive overview of the management of high bleeding risk (HBR) patients with multivessel disease. Through expert discussion and a live case demonstration featuring a complex elderly patient, it highlights how intracoronary imaging and physiology can guide procedural decisions and improve outcomes in this...
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
